
The Founder and Chief Executive Officer of Emzor Pharmaceutical Industries Limited, Dr Stella Okoli, has called for medicine security to become a national priority, urging Nigeria to strengthen its capacity to meet its pharmaceutical needs. She warned that Nigeria cannot continue to depend excessively on foreign sources for essential medicines and pharmaceutical raw materials, given the lessons of past experiences.
Speaking at the World Pharmacists Day celebration organised by the Ogun State Zone of the Association of Industrial Pharmacists of Nigeria (NAIP), Okoli called for stronger local pharmaceutical manufacturing, increased investment in research and development, and greater collaboration among industry, government, academia and regulatory institutions.
Her address was delivered by Emzor’s Regulatory Affairs Manager, Pharm. Colette Okwuchi, who represented her as chairman of the occasion. Okoli said industrial pharmacists and other stakeholders in pharmaceutical manufacturing have a special responsibility to help build a more self-reliant pharmaceutical industry.
She said Nigeria’s continued dependence on foreign sources for essential medical commodities and pharmaceutical raw materials is unsustainable, stressing that medicine security must become a national priority.
“As industrial pharmacists and stakeholders in the pharmaceutical manufacturing sector, we also have a special responsibility to Nigeria. We cannot continue to have a nation that depends excessively on the outside world for essential medical commodities or pharmaceutical raw materials. Medicine security must become a national priority,” she said.
According to Okoli, achieving medicine security would require Nigeria to strengthen its local manufacturing capacity while investing significantly in research and development, human capital, technology and infrastructure.
“We must strengthen local manufacturing, we must invest in research and development, we must develop our human capital, we must improve technology and infrastructure,” she said.
She also stressed the need for deeper collaboration among pharmaceutical companies, government, academic institutions and regulatory bodies. Such partnerships, she said, are necessary to create an environment in which Nigerian pharmaceutical companies can grow, compete and produce medicines that met globally accepted standards.
“And most importantly, we must create an environment where Nigerian pharmaceutical industries can grow, compete and produce to globally acceptable standards,” she added.
The Emzor founder noted that the future of Nigeria’s pharmaceutical industry should not be measured simply by the volume of medicines produced, but also by its ability to manufacture quality and effective medicines in sufficient quantities to meet the needs of the Nigerian population.
She said initiatives aimed at strengthening pharmaceutical manufacturing, including the development of active pharmaceutical ingredients, should be regarded as important components of Nigeria’s medicine security and healthcare independence.
“The future of Nigeria’s pharmaceutical industry cannot simply be about producing more medicines. It must be about producing better and effective medicines in the right quantities and quality, sufficient to meet the needs of the Nigerian public,” she said.
Okoli also urged younger pharmacists to play an active role in shaping the future of the profession and the pharmaceutical industry. She encouraged them to combine professional excellence with integrity, innovation, responsibility and service.
Describing the younger generation as an important part of both the present and future of pharmacy, she urged young pharmacists to explore new ideas without compromising their professional values.
Beyond local production, she called for a united approach to addressing the challenges facing Nigeria’s pharmaceutical sector, stressing that no individual, company, association or institution could transform the industry alone.
“The industry needs the government. The government needs the industry. The industry needs the regulators,” she said, adding that academia also needs industry collaboration, while young professionals need mentorship.
Dr Okoli urged stakeholders to build stronger partnerships and share knowledge, saying collaboration would help advance Nigeria’s pharmaceutical industry.
“Let us therefore continue to build bridges rather than build walls. We must share knowledge with one another rather than guard it unnecessarily, and create partnerships that will move the pharmaceutical industry forward,” she said.
She expressed optimism that, with unity of purpose and a commitment to excellence, Nigeria could build a pharmaceutical sector capable of meeting the country’s needs and earning greater recognition across Africa and the world.
She also commended NAIP Ogun Zone for organising the World Pharmacists Day celebration and providing a platform to recognise excellence within the profession.
The event also featured the distribution of free medicines to residents of Sango-Ota and sensitisation on the dangers of drug abuse as part of activities marking the celebration.





